In addition, substantial progress has been made in our understanding of individual ISGs (ISG15, IFIT2, IFITM3) in CNS viral infection and diseases in recent years (Table 1), providing an essential target for the development of novel antivirals and anti-neurological disease drugs. Here, IFITM3 is linked to nervous system disorder.